KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Boston Scientific (BSX) Return on Sales (2016 - 2025)

Boston Scientific's Return on Sales history spans 17 years, with the latest figure at 0.13% for Q4 2025.

  • For Q4 2025, Return on Sales changed 0.0% year-over-year to 0.13%; the TTM value through Dec 2025 reached 0.14%, up 3.0%, while the annual FY2025 figure was 0.14%, 3.0% up from the prior year.
  • Return on Sales for Q4 2025 was 0.13% at Boston Scientific, down from 0.15% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.16% in Q2 2025 and bottomed at 0.03% in Q4 2021.
  • The 5-year median for Return on Sales is 0.12% (2024), against an average of 0.1%.
  • The largest annual shift saw Return on Sales grew 20bps in 2021 before it fell -9bps in 2022.
  • A 5-year view of Return on Sales shows it stood at 0.03% in 2021, then soared by 46bps to 0.04% in 2022, then surged by 211bps to 0.14% in 2023, then fell by -9bps to 0.12% in 2024, then rose by 3bps to 0.13% in 2025.
  • Per Business Quant, the three most recent readings for BSX's Return on Sales are 0.13% (Q4 2025), 0.15% (Q3 2025), and 0.16% (Q2 2025).